Abstract
Abstract
Purpose of Review
This integrative search aimed to provide a scoping overview of the relationships between the benefits and harms of alcohol drinking with cardiovascular events as associated to body fat mass and fatty liver diseases, as well as offering critical insights for precision nutrition research and personalized medicine implementation concerning cardiovascular risk management associated to ethanol consumption.
Recent Findings
Frequent alcohol intake could contribute to a sustained rise in adiposity over time. Body fat distribution patterns (abdominal/gluteus-femoral) and intrahepatic accumulation of lipids have been linked to adverse cardiovascular clinical outcomes depending on ethanol intake. Therefore, there is a need to understand the complex interplay between alcohol consumption, adipose store distribution, metabolic dysfunction-associated steatotic liver disease (MASLD), and cardiovascular events in adult individuals. The current narrative review deals with underconsidered and apparently conflicting benefits concerning the amount of alcohol intake, ranging from abstention to moderation, and highlights the requirements for additional robust methodological studies and trials to interpret undertrained and existing controversies.
Summary
The conclusion of this review emphasizes the need of newer multifaceted clinical approaches for precision medicine implementation, considering epidemiological strategies and pathophysiological mechanistic. Newer investigations and trials should be derived and performed particularly focusing both on alcohol’s objective consequences as putatively mediated by fat deposition, including associated roles in fatty liver disease as well as to differentiate the impact of different levels of alcohol consumption (absence or moderation) concerning cardiovascular risks and accompanying clinical manifestations. Indeed, the threshold for the safe consumption of alcoholic drinks remains to be fully elucidated.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Reference122 articles.
1. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases, 2013–2020. 2013. https://www.who.int/publications/i/item/9789241506236. Accessed 27 Dec 2023.
2. Burton R, Sheron N. No level of alcohol consumption improves health. Lancet (London, England). 2018;392:987–8. https://doi.org/10.1016/S0140-6736(18)31571-X.
3. Shield K, Manthey J, Rylett M, Probst C, Wettlaufer A, Parry CDH, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Heal. 2020;5:e51-61. https://doi.org/10.1016/S2468-2667(19)30231-2.
4. Casswell S. Will alcohol harm get the global response it deserves? Lancet (London, England). 2019;394:1396–7. https://doi.org/10.1016/S0140-6736(19)31883-5.
5. Martínez-González MA, Barbería-Latasa M, Pérez De Rojas J, Domínguez Rodriguez LJ, Gea Sánchez A. Alcohol and early mortality (before 65 years) in the “Seguimiento Universidad de Navarra” (SUN) cohort: does any level reduce mortality? Br J Nutr. 2022;127:1415–25. https://doi.org/10.1017/S0007114521002397.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献